Related Experiment Videos
Retrospective Analysis of Adverse Drug Reactions in Patients with Type 2 Diabetes Mellitus and Development of a Risk
Bo Sun1, Qian Guan2,3, Qin Zhou2,3
1Department of Endocrinology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
Background:
Patients with diabetes are prone to adverse drug reactions (ADRs) during long-term medication, but the related risk factors and predictive models remain to be clarified.
Objective:
To analyze the influencing factors of ADRs in patients with type 2 diabetes mellitus (T2DM) and to develop and validate a risk prediction model.
Methods:
Clinical data of 254 randomly selected patients with T2DM were retrospectively analyzed. Patients were divided into a control group (n=198) and an ADR group (n=56) based on the presence of ADRs. Multivariate logistic regression was used to identify independent risk factors associated with the occurrence and establish a prediction model.
Results:
Among the 56 patients who experienced ADRs, insulin hypoglycemic drugs had the highest proportion of adverse reactions (33.93%). Age ≥ 60 years old, three or more type medication, three or more comorbidities, abnormal BMI (> 24 or < 18 kg/m2), and length of hospitalization > 7 days were independent risk factors associated with the occurrence of ADRs (P < 0.05). A multivariate logistic regression model incorporating age, medication type, number of comorbidities, body mass index, and length of hospitalization demonstrated good predictive performance, with an accuracy of 85.43%, sensitivity of 83.93%, and specificity of 85.86%.
Conclusion:
The above five indicators are independent risk factors associated with the occurrence of ADRs in patients with T2DM. The risk prediction model has certain predictive performance and may help early identification of high-risk patients.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Risk factors